+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
Licensing Deals in Biotechnology 2019-2024 - Product Thumbnail Image

Licensing Deals in Biotechnology 2019-2024

  • Report
  • September 2024
  • 1250 Pages
  • Global
From
Collaboration Deals in Biotechnology 2019-2024 - Product Thumbnail Image

Collaboration Deals in Biotechnology 2019-2024

  • Report
  • September 2024
  • 1200 Pages
  • Global
From
From
From
From
Lupus Nephritis - Pipeline Insight, 2024 - Product Thumbnail Image

Lupus Nephritis - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 80 Pages
  • Global
From
From
Hypophosphatasia Treatment Global Market Report 2024 - Product Thumbnail Image

Hypophosphatasia Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Fibromyalgia Treatment Global Market Report 2024 - Product Thumbnail Image

Fibromyalgia Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Synthetic Biology: Global Markets - Product Thumbnail Image

Synthetic Biology: Global Markets

  • Report
  • August 2024
  • 137 Pages
  • Global
From
From
Loading Indicator